Home / Intelligence / Webinars / Generative AI in Pharma – Five Years From Now
Available On Demand
Generative AI is having a transformative impact on the pharmaceutical industry. Drugmakers are partnering up with companies like Insilico Medicine, Exscientia, BenevolentAI, and more to leverage their respective generative AI-powered platforms and applying them across the pharma value chain: from accelerating drug discovery and optimizing clinical trials, to improving operational efficiencies and enabling personalized treatments that promise better outcomes.
What progress has been made by the pharma companies in integrating generative AI into their operations and what advances would we see five years from now?
This live event will speak to industry experts to get their perspectives and predictions on how current trends will shape the future of generative AI in pharma.
Featuring
Related Intelligence
Webinars
The GenAI Advantage: Empowering Pharma Customer-Facing Teams
June 11, 2025 | 1:00 – 1:45 PM ET
Additional sessions will be offered on:June 12 – 12:00 (UTC +8:00) – Asia/ShanghaiJune 12 – 12:00 CET – Europe/Berlin Join us for the first webinar in our “AI Innovations in Life Sciences” series to learn how generative AI (GenAI) can transform the way customer-facing teams (sales reps and medical science liaisons) operate in life sciences […]
Sign Up Now
White Papers
Technology with a Point of View: Encoding Life Sciences Expertise with AI
As an industry, life sciences is now looking towards technological change to leverage investments made during the past few years. In fact, according to Trinity’s TGaS Advisors, the proportion of surveyed companies reporting that they have completed proof of concept or are using GenAI at an enterprise level for commercial, medical, or customer operations surged […]
Read More
Blog
Operationalizing Generative AI in Life Sciences—Trinity Life Sciences Included in Everest Group Report
The transformative potential of generative AI (GenAI) within the life sciences industry is highlighted in Everest Group’s report, “AI-deas to Action: Operationalizing Generative AI in Life Sciences.” Fifteen companies were selected for inclusion across three categories: To be included in the report, providers had to have been profiled in past Everest Group PEAK Matrix® […]
Read More